Science Explorer Back to mapMap
Discussion
Research facility · Changzhou · China

Zonhon Biopharma Institute

zonhonbio.comROR OpenAlex
Research works
1
▲ 4% vs 2018-21
Citations
44
31.7 per fractional work
Top-10% rate
0.0%
all institutions 10.0%
Open access
67%
world 40%
International
48%
world 18%
Zonhon Biopharma Institute

Not ranked overall: Zonhon Biopharma Institute is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Zonhon Biopharma Institute work in?

In all years, 47% of research at Zonhon Biopharma Institute is in Life Sciences, 40% in Physical Sciences. Its largest fields are Engineering (33%), Immunology and Microbiology (20%), Agricultural and Biological Sciences (13%).

Life Sciences: 1 fractional works · 46.7% of its workImmunology and Microbiology: 0 fractional works · 20.0% of its workAgricultural and Biological Sciences: 0 fractional works · 13.3% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 13.3% of its workPhysical Sciences: 1 fractional works · 40.0% of its workEngineering: 0 fractional works · 33.3% of its workMaterials Science: 0 fractional works · 6.7% of its workHealth Sciences: 0 fractional works · 13.3% of its workMedicine: 0 fractional works · 13.3% of its workALL ITS WORKZonhon BiopharmaInstitute2fractional works, all years
Life Sciences47%Physical Sciences40%Health Sciences13%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 6 fields, with their numbers
    1. Immunology and Microbiology020.0%
    2. Agricultural and Biological Sciences013.3%
    3. Biochemistry, Genetics and Molecular Biology013.3%
    1. Engineering033.3%
    2. Materials Science06.7%
    1. Medicine013.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Zonhon Biopharma Institute?

The most cited paper from Zonhon Biopharma Institute is "3D bioprinting of BMSC-laden methacrylamide gelatin scaffolds with CBD-BMP2-collagen microfibers" (Mingchun Du, Bing Chen, Qingyuan Meng et al., 2015), with 142 citations. Next come "Mannan-Binding Protein, a C-Type Serum Lectin, Recognizes Primary Colorectal Carcinomas through Tumor-Associated Lewis Glycans" (25) and "Yi-Qi-Huo-Xue decoction alleviates intracerebral hemorrhage injury through inhibiting neuronal autophagy of ipsilateral cortex via BDNF/TrkB pathway" (12).

Most cited papers
#PaperReleasedCitations
1 3D bioprinting of BMSC-laden methacrylamide gelatin scaffolds with CBD-BMP2-collagen microfibers Mingchun Du, Bing Chen, Qingyuan Meng et al. · Biofabrication Open access 18 Dec 2015 142
2 Mannan-Binding Protein, a C-Type Serum Lectin, Recognizes Primary Colorectal Carcinomas through Tumor-Associated Lewis Glycans Motohiro Nonaka, Hirotsugu Imaeda, Shogo Matsumoto et al. · The Journal of Immunology 4 Jan 2014 25
3 Yi-Qi-Huo-Xue decoction alleviates intracerebral hemorrhage injury through inhibiting neuronal autophagy of ipsilateral cortex via BDNF/TrkB pathway Dan Han, Xinyue Chang, Dan Xu et al. · Phytomedicine Open access 19 Feb 2024 12
4 pH-sensitive magnetic drug delivery system via layer-by-layer self-assembly of CS/PEG and its controlled release of DOX Juan Wu, Xi Wang, Binglong Zhu et al. · Journal of Biomaterials Science Polymer Edition 16 Mar 2020 12
5 Unraveling amino acid sequence features that confer high calcium-binding capacity to soybean peptides and improve absorption in caco-2 cells Jiulong An, Man‐Qun Wang, Wanlu Liu et al. · Journal of Functional Foods Open access 22 May 2025 7
All 7 most cited papers, with filters and sorting

Which research topics does Zonhon Biopharma Institute publish most on?

By volume in 2022-now: Protein Hydrolysis and Bioactive Peptides, Antimicrobial Peptides and Activities, Proteins in Food Systems and Immune cells in cancer.

Protein Hydrolysis and B…0Protein Hydrolysis and Bioactive Peptides: 0 fractional worksAntimicrobial Peptides a…0Antimicrobial Peptides and Activities: 0 fractional worksProteins in Food Systems0Proteins in Food Systems: 0 fractional works
Molecular BiologyMicrobiologyFood Science

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Protein Hydrolysis and Bioactive Peptides Molecular Biology 0 works
  2. 2 Antimicrobial Peptides and Activities Microbiology 0 works
  3. 3 Proteins in Food Systems Food Science 0 works
  4. 4 Immune cells in cancer Immunology 0 works
  5. 5 Intracerebral and Subarachnoid Hemorrhage Research Neurology 0 works
  6. 6 Autophagy in Disease and Therapy Epidemiology 0 works
  7. 7 Insect and Pesticide Research Insect Science 0 works
  8. 8 Insect and Arachnid Ecology and Behavior Genetics 0 works
  9. 9 Bee Products Chemical Analysis Insect Science 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available67.1%not open32.9%

World: 40% of research is openly available.

with international co-authors47.9%domestic only52.1%

World: 18% is written across borders.

How has Zonhon Biopharma Institute's research output changed?

Output in 2022-2025 was 4% higher than in 2018-2021.

still counting201520202025

Other research institutions in Changzhou

All research institutions in Changzhou

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Zonhon Biopharma Institute. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.